The use of alteplase in a newborn with an aortic arch thrombus during extracorporeal membrane oxygenation.
Lijun YangLifen YeRu LinPublished in: Cardiology in the young (2019)
We report a neonatal case of the use of alteplase for the lysis of a large aortic arch thrombus formed during extracorporeal membrane oxygenation support. Alteplase (0.1-0.15 mg/kg/hour) was infused for thrombolysis, and meanwhile, unfractionated heparin was administrated at 5-10 U/kg/hour for the anticoagulation purpose. Alteplase was successfully administered to this neonate after the repair of congenital diaphragmatic hernia on extracorporeal membrane oxygenation, and the patient survived without apparent catastrophic long-term complications. It is reasonable to consider alteplase therapy during extracorporeal membrane oxygenation support in this setting.
Keyphrases
- extracorporeal membrane oxygenation
- acute ischemic stroke
- acute respiratory distress syndrome
- respiratory failure
- blood pressure
- venous thromboembolism
- atrial fibrillation
- pulmonary embolism
- computed tomography
- risk factors
- case report
- magnetic resonance imaging
- stem cells
- growth factor
- mesenchymal stem cells
- bone marrow
- diffusion weighted imaging
- smoking cessation
- replacement therapy